Joshua Boger, Alkeus Pharmaceuticals executive chairman

Bain leads $150M round to push blind­ness biotech's rare dis­ease drug to­ward FDA

Alkeus Phar­ma­ceu­ti­cals has raised $150 mil­lion via a Se­ries B round in or­der to ad­vance a pre­ci­sion med­i­cine can­di­date to treat Star­gardt dis­ease, a cur­rent­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.